Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α

PURPOSE: Anti-vascular endothelial growth factor (VEGF) agents have recently been used intravitreally during the perioperative period for proliferative diabetic retinopathy (PDR). However, the mechanism of theraputic effects of the agents remains unclear. This study aimed to investigate the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiao-Xia, Guo, Chang-Mei, Li, Yue, Hui, Yan-Nian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253067/
https://www.ncbi.nlm.nih.gov/pubmed/22232563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253067/
https://www.ncbi.nlm.nih.gov/pubmed/22232563

Ejemplares similares